Celebration World Cancer Day It also acts as the starting point for the ambitious and confident challenge for the future marked Astrajenca: Try to eliminate cancer for a cause of death. A track that begins ‘Project: Cancer zero’A series of five articles made by institutional experts and cancer specialists, in which features such as programs are analyzed Premature diagnosis, the need to guarantee accurate medicine and equity In access to innovative treatments, in other problems.
Each article of the initiative provides a perspective. Together, they express the basic confidence of the pharmaceutical company The possibility of important science progress The challenges to be overcome at the same time are considered. The Spanish Society of Medical oncology (SEOM) assesses it Cancer survival in Spain has doubled over the last 40 years Slowly, it will continue to increase in the coming years. Of course, you have to do a lot more.
Towards zero cancer
Rick sures. Now we understand why and how the tumors are formedAnd how to use technology to detect and treat cancer. This has already made important improvements in cancer decisions. However, despite the great belief in this golden age and the future of science, this time “there are people who live with cancer, who is You can only see your life increased in a few months”.
In view of this, Suarez says that asthrajenga is investing in a wide range of new potential drugs, Novel tools like artificial intelligence To improve innovative diagnosis and treatment, such as immune therapy or cell therapies, all of which are essential to move the ambition of zero deaths by cancer – and many more. “If we act now, there is a real possibility to redefine the meaning of cancer detection and to create a future that has been eliminated as a cause of cancer death. If we all work in the same direction, zero cancer is possible”, He concludes.
If we all work in the same direction, zero cancer is possible
Early diagnosis and cancer prevention
In his article, the Dr. Lorion MollsCoordinator of lung coalition ambition, refers to it Early detection and prevention is underlined as the key to improve the quality of life and survivalIn the face of a diagnosis, when done in late stages, the treatment of treatment affects the planning and makes a heavy load. “It is necessary for a constant health system to delay the appearance of diseases and lasting life expectancy,” he says. Cancer cases are estimated that 30% to 50% are prevented, and the actions such as smoking and obesity are the main factors.
Entertainment of antibody paper in the treatment of cancer / Ashrajenca
The TechnologyAccording to the expert, he plays an important role in the early diagnosis. The artificial intelligence used for image analysis and fluid tumor DNA biopsy ensures improvements to improve the diagnosis and treatment. Programs to connect the screening barrier are proven It is useful to reduce death and costs associated with cancer. With these advances, premature detection of cancer will play an important role in its eradication.
Improve the survival of patients with cancer
Dr. Rosario Garcia CampelloIn his article, the host of the Astrajenka Foundation and the president of a Korusa (Suk) Medical Cancer Service University Hospital complex, in his article, requires social, political and medical effort to improve the survival of cancer patients. He emphasizes that “all patients can only ensure that all patients have diagnostic and customized treatments, which will reduce death and have a positive impact on their quality of life.”
In recent decades, survival in Spain has increased, but tumors such as pancreas and liver have regularly low survival rates. To improve this situation, it is important Increase investment in researchImplementation of early prevention and diagnostic programs, creating more effective treatment, ensuring health care to health care, and promoting cooperation among medical professionals. “Every step towards this purpose refers to an opportunity to change life and have a significant impact on the fight against cancer,” he says.
Reducing cancer from accurate medicine
Accuracy It has emerged as an important strategy in treating cancer, embracing those who treat each patient’s specific genetic and molecular properties, and their article is highlighted Lorera colonDirector of Astrajenka’s Cancer. This approach is based on scientific and technological advances, with the ambition to develop the most effective treatment with low side effects.
Astrajenca Cancer Research Laboratory. / Ashrajenca
“For example, the presence of some genetic changes in a tumor may indicate that it is likely to respond to specific directed treatment.” In addition, they are growing up ”Treatments that select DNA damage repair instructions for tumor cells“. Immunity therapy is also an important improvement that affects the patient’s immune system. In addition, the combination of synthetic intelligence with ‘large data’ Creating more accurate diagnosis and customized treatments Thanks for the analysis of large -scale data.
Challenges in Equality of Cancer Care in Spain
Marta MoroAccess to the Director of Corporate Affairs and Astrajenka Market, protects their article The role of the maintenance of cancer is an important purpose To ensure that all patients get quality care regardless of their geographical location, socioeconomic condition, or the type of cancer. “Despite the good indicators of the Spanish health organization, more than half of the population considers that there is no equality in treating cancer, according to the autonomous society that resides,” he says.
To move towards the most equal attention, astrajenca reveals three major parts: the Access to screening and early diagnosis, determine biomarks for customized treatments and get innovative treatments. As for the screening, there are imbalances due to regional and educational barriers. As for biomarks, the latest list of genetic tests 5 is an important step to guarantee its national access. However, the delay in the availability of innovative treatments in Spain is a challenge if already recognized in Europe, Up to 725 days with average delay compared to other European countries Like Germany, the delay is 3 months 6.
“We are firmly confident that in the process of working with health institutions and experts, we are firmly confident that in Spain, cancer will be diluted,” says Moreno. With these advances, the future of cancer is approaching for more effective treatment, customization and improve the lives of patients.
